MVD Antikörper (AA 201-300)
Kurzübersicht für MVD Antikörper (AA 201-300) (ABIN709451)
Target
Alle MVD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-300
-
Kreuzreaktivität
- Maus, Ratte
-
Homologie
- Human,Dog,Cow,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MVD
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- MVD (Mevalonate (Diphospho) Decarboxylase (MVD))
-
Andere Bezeichnung
- MVD
-
Hintergrund
-
Synonyms: Diphosphomevalonate decarboxylase, FP17780, MDDase, Mevalonate diphospho decarboxylase, Mevalonate diphosphodecarboxylase, Mevalonate pyrophosphate decarboxylase, MPD, Mvd, MVD1_HUMAN__
Background: The enzyme mevalonate pyrophosphate decarboxylase (MVD) catalyzes the conversion of mevalonate pyrophosphate into isopentenyl pyrophosphate in one of the early steps in cholesterol biosynthesis. It decarboxylates and dehydrates its substrate while hydrolyzing ATP.
-
Gen-ID
- 54925
Target
-